IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Polaris Venture Management Co. V, L.L.C.

Q3 2021 Holdings

Filed 2021-11-12 | 6 holdings | $14.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Lyra Therapeutics, Inc.(LYRA)Common Stock55234L105$10.0K1,100,85271.3%
x4 Pharmaceuticals Inc.(ASNSUSD)Common Stock98420X103$1.6K311,49211.7%
Atyr Pharma Inc.(LIFEUSD)Common Stock002120103$1.2K130,5728.4%
Dare Bioscience, Inc.(CERUEUR)Common Stock23666P101$545326,2403.9%
Genocea Biosciences, Inc.(GNCAQ)Common Stock372427401$379197,3452.7%
Pulmatrix, Inc.Common Stock74584P202$288359,4412.0%